We have completed a Phase 1 clinical trial evaluating XmAb2513 for Hodgkin’s lymphoma and anaplastic large cell lymphoma.
More information can be found at www.clinicaltrials.gov.
Additional information is available through the following organizations:
The Leukemia & Lymphoma Society
Visit www.LLS.org/clinicaltrials or contact the Society’s Information Resource Center at 800-955-4572 or via e-mail at infocenter@LLS.org to contact an Information Specialist (in English or Spanish).